Abstract. The model of Notch-driven carcinogenesis and development of hepatocellular carcinoma remains controversial and is based on observations of developmental stage-and dose-dependent Notch activation. In this study, the relevance of the spatial distribution of Notch cascade members to the promotion of hepatocellular carcinoma metastasis was evaluated. The spatial expression patterns of the members of the Jagged1 (JAG1)/Notch1 cascade in HCC were evaluated in a tissue microarray of 112 tumors and 46 peri-tumors. Regulation of JAG1/Notch1 on osteopontin (OPN) was evaluated by RNA interference. Tumor cells with JAG1 expressed on the membrane (JAG1 Mem ) were more likely to undergo extrahepatic metastasis [p<0.001; hazard ratio (HR), 0.166; 95% CI, 0.068-0.402], and JAG1
Introduction
Notch signaling is involved in the tumorigenesis and progression of nearly all solid tumors (1), which makes this cascade a highly desirable therapeutic target. In particular, Notch signaling has been shown to be involved in the tumorigenesis and proliferation of hepatocellular carcinoma (HCC). However, the reports on this topic have been contradictory (2) (3) (4) (5) (6) , and the differential expression patterns of Notch cascade members are correlated with this variability in results. In the liver, Notch acts in a developmental stage-and dose-dependent manner to coordinate biliary fate and morphogenesis (7) , and similar activities have also been detected in HCC. However, temporal and concentration differences in the Notch cascade cannot completely explain the discrepancies in the Notch-related findings in HCC, which suggests the existence of other factors that affect Notch activation in HCC.
Notch signaling is controlled at multiple levels, including through gene dosage sensitivity (8) and through cis and trans interactions between the ligand and receptor on neighboring cells or on the same cell membrane (9) . Unlike most major signaling pathways, which rely on enzymatically amplified signals, Notch signaling is mediated by stoichiometric interactions between the elements of the pathway. The stoichiometric difference between receptor and ligand expression on the membrane is an important factor that affects the signaling between two interacting cells (10) . Additionally, post-translational modifications introduced in the cytoplasm, such as ubiquitylation, glycosylation and phosphorylation, have emerged as key regulators of Notch signaling (11) (12) (13) . Therefore, the localization of Jagged1 (JAG1) and Notch1 to the membrane or the cytoplasm directly correlates with the activity of the Notch cascade. Thus, we directed our attention to the effects of the spatial distribution of Notch signaling factors on HCC progression.
Similar to its role in organ development (14) , Notch signaling impacts tumor metastasis by regulating epithelial-mesenchymal transition (EMT)-related genes (15) . Breast cancer and prostate tumor models have indicated that JAG1 mediates EMT through the up-regulation of Slug and AKT signaling (16, 17) . Recent data have further indicated that osteopontin (OPN), another EMT-related gene, is dramatically up-regulated as a result of Notch activation in HCC, suggesting that OPN is one of the main target genes of Notch signaling in HCC (18) . Our previous research demonstrated the crucial role of OPN in HCC metastasis (19) and suggested that the JAG1-Notch1-OPN axis may play a pivotal role in HCC metastasis.
In this study, we used immunohistochemical analyses of tissue microarrays (TMAs) to evaluate whether the localization patterns of the Notch1 cascade members could affect HCC metastasis. The predictive value of the localization of JAG1-Notch1-OPN cascade members in HCC metastasis was also evaluated.
Materials and methods
Cell line. Human HCC cell lines with different metastatic potential, or MHCC97H (100% lung metatsis) and MHCC97L were established in Liver Cancer Institute of Fudan University (Shanghai, China). HCC cell line SMMC-7721 was established at Second Military Medical University (Shanghai, China); Hep3B, and HepG2 were obtained from American Type Culture Collection (Manassas, VA, USA). L02, an immortalized human liver cell line, and HCC cell lines Huh7 and HCC-7402 was obtained from Chinese Scientific Academy. The cell line was cultured in high glucose DMEM (Gibco-BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Hyclone Laboratories, Inc., Logan, UT, USA).
Patients and follow-up. One hundred twelve patients were sampled from a prospectively designed database. Ethical approval was obtained from the Zhongshan Hospital Research Ethics Committee, and informed consent was obtained from each patient. The included patients underwent hepatectomy by the same surgical team between January, 2000 and May, 2004. All of the patients had pathologically diagnosed HCC and were classified as Child-Pugh A. Routine follow-up procedures at our clinic were performed as previously described (20) . Through May 2009, 56 patients were found to have lung metastasis. Ten patients with a resectable lung metastasis received a partial pneumonectomy.
TMA and immunohistochemistry. First, hematoxylin and eosin-stained slides were screened for optimal tumor content and at least 2 cm of tissue adjacent to the tumor (TAT). Then, the TMA was constructed according to standard procedures (21) . Rabbit anti-human JAG1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 1:50, rabbit anti-human Notch1 (Epitomics, Burlingame, CA, USA) at 1:100 and rabbit antihuman OPN (Santa Cruz Biotechnology) at 1:200 were used as primary antibodies for detection. Detection without a primary antibody was used as a negative control.
Categories of JAG1 and Notch1 expression. Two categories for JAG1 expression were established based on the distribution of immunostaining patterns: JAG1
Mem which has clear membrane expression no matter whether expression level in cytoplasm; and JAG1
Cyto which only can be detected the cytoplasm expression). Similarly, Notch1 expression was categorized as Notch1
Mem and Notch1 Cyto based on the spatial staining pattern. Two pathologists reviewed the results independently. In addition, because OPN was only evaluated as a target of the JAG1-Notch1 cascade, we categorized OPN expression as negative or positive based on the staining intensity.
Western blot analysis. Membrane protein was extracted according to the instructions of Mem-PER Plus Membrane Protein Extraction Kit (Thermo Fisher Scientific, Rockford, IL, USA). Western blot analysis was performed according to the protocol of Bio-Rad wet transfer using the Bio-Rad Transfer Cell System (Bio-Rad, Mississauga, ON, Canada). Analyses of protein expression were performed according to the manufacturer's instructions. Rabbit anti-human JAG1 (Santa Cruz Biotechnology) 1:200, rabbit anti-human Notch1 (Epitomics) at 1:1,000, rabbit anti-human OPN (Abcam, Cambridge, MA, USA) at 1:1,000 and rabbit anti-human β-actin mAb (Epitomics) 1:1,000 were used as primary antibodies in detection. 
Statistical analysis. Pearson's χ
2 test was used to compare qualitative variables in the clinical pathology analysis. When the expected sample numbers were below 5, Fisher's exact test was used. Spearman's rank test was used to detect the correlation between variables. The survival analysis included time-to-lung metastasis, overall survival (OS) and time-to-progression (TTP). The time-to-lung metastasis was calculated from the date of hepatectomy to the date of lung metastasis with a definite clinical diagnosis. The Kaplan-Meier method was used to generate the survival curves, and the log-rank test was used to compare the survival distributions between the groups. The log-rank test was also used to screen for prognostic factors in the univariate analysis. A Cox regression model was used to identify the prognostic factors related to the time-to-lung metastasis. A receiver operation curve (ROC) was used to confirm the predictive accuracy of the prognostic factors. All of the p-values were 2-tailed, and statistical significance was set at 0.05. The statistical analyses were completed using SPSS 18.0 software (SPSS Inc., Chicago, IL, USA).
Results

Tumor cells with JAG1
Mem are more likely to undergo metastasis. The 112 tumors evaluated demonstrated JAG1 expression; 39 exhibited membrane expression, and 73 exhibited cytoplasmic expression. Fig. 1 shows a representative image of strong JAG1 staining in the membranes of neighboring tumor cells.
In patients with lung metastasis (n=56), 54% ( Mem correlated positively with metastasis (Spearman's rho =0.394; p=0.000). In addition, there were no statistically significant differences in any clinicopathological variables between JAG1
Mem and JAG1
Cyto samples, with the exception of the tumor capsule (Table I) ; tumors with JAG1 Mem had a more poorly encapsulated membrane (Spearman's rho =0.232; p=0.014).
Patients with JAG1 Mem tumors were also more likely to experience lung metastasis within a shorter period of time compared to those with JAG1 Cyto tumors. In the JAG1 Cyto group, the cumulative 1-, 3-and 5-year rates of lung metastasis-free were 73, 66 and 64%, respectively, whereas in the JAG1 Mem group, the cumulative 1-, 3-and 5-year rates were 51, 31 and 22%, respectively. The time-to-lung metastasis for the JAG1 Mem group was significantly shorter than that for the JAG1 Cyto group (p<0.001, log-rank test). The curve for time-to-lung metastasis is shown in Fig. 2A . In addition, there were significant differences in the OS and TTP between the JAG1 Mem and JAG1
Cyto groups (log-rank test, p=0.024 and p=0.002, respectively) ( Fig. 3A and C) . Cyto . The typical membrane staining for Notch1 could also be observed in neighboring tumor cells (Fig. 4) .
Overall, 63% (n=26) of the samples from patients with lung metastases (n= 41) were classified as Notch1
Mem , whereas in the patients without lung metastasis (n=48), only 18 samples were Notch1
Mem . Furthermore, tumors with Notch1 Mem expression were highly likely to undergo extra-hepatic metastasis (HR, 1.773, 95% CI, 1.096-2.867; p=0.015), and Notch1
Mem was positively correlated with metastasis (Spearman's rho =0.258; p= 0.015). In addition, there were no statistically significant differences in any clinicopathological variables between JAG1
Mem and JAG1 Cyto (data not shown).
Patients with Notch1
Mem tumors were more likely to develop lung metastases in a shorter period of time. The time-to-lung metastasis for the Notch1
Mem group was also significantly shorter than that in the Notch1
Cyto group (log-rank test; p=0.05). The time-to-lung metastasis curves are shown in Fig. 2B . In addition, there were potential differences in OS and 
TTP between the Notch1
Mem and Notch1 Cyto groups (log-rank test, p=0.066 and p=0.065, respectively) ( Fig. 3B and D) . (Fig. 5B) . Mem groups had a shorter time to the development of extra-hepatic metastasis compared to the JAG1 Cyto and Notch1 Cyto groups, respectively (Kaplan-Meier, log-rank test). Table I . Correlation between the localized expression of JAG1 and the clinical characteristics of 112 patients with hepatocellular carcinoma. sion in TATs, including 23 peri-tumor tissues from patients with metastasis and another 23 peri-tumor tissues from patients without metastasis. Generally, the immuno-staining for JAG1 and Notch1 in the peri-tumor tissue was weaker than that in the tumors; only one of the 46 TATs evaluated was of the JAG1 Mem type. The distribution of JAG1 Cyto in most of the peri-tumor samples was homogenous. Small JAG1-positive granules were found in the cytoplasm (Fig. 1D) . Similar to JAG1, Notch1 expression was localized to the cytoplasm in most of the peri-tumor samples (41/46). In addition, in the Notch1
JAG1
No. of patients ----------------------------------------------
Cyto samples, the Notch1 protein typically aggregated in the cytoplasm in a granule-type pattern, which was either well distributed or regional (Fig. 4E-F Mem positively correlated with OPN expression (Spearman's rho =0.195; p=0.042). In tumor cells in which JAG1 was clearly stained on the membrane, OPN was expressed either in aggregates or uniformly (Fig. 6A) , whereas in JAG1 Cyto tumor cells, OPN was expressed relative lowly (Fig. 6B) .
Knockdown of JAG1-Notch1 downregulated the OPN level.
The membrane expression of JAG1-Notch1 and the coincidence of expressions between JAG1-Notch1 and OPN were detected in HCC cell lines. As shown in Fig. 6C , the most of examined HCC cells had upregulated membrane expressions of both JAG1 and Notch1 when compared to normal liver cell line L02. Particularly, highly metastatic MHCC97H had strong membrane expression and cytoplasm expression of JAG1, with the consistently high expression of OPN. Further, downregulation of JAG1 expression in MHCC97H decreased OPN level. Similarly, knockdown of Notch1 induced the downregulation of OPN expression in HCC cells (Fig. 6D ).
Discussion
Although a developmental stage-and dose-dependent mechanism of action for the Notch cascade was previously observed in HCC and liver tissues, the reports concerning Notchdriven carcinogenesis and HCC progression are controversial (1, 22, 23) and suggest another possible mechanism of Notch activation. To our knowledge, this study is the first to show that the spatial distributions of Notch signaling proteins affect their roles in the development of HCC.
Notch signaling has been shown to have unique features, including gene dosage sensitivity and both cis and trans regulation mechanisms. Our findings suggest that enhanced membrane localization and expression may lead to an increased opportunity for signal communication and activation between neighboring tumor cells. In addition, strong JAG1
Mem and Notch1 Mem expression likely leads to increased trans interactions between cells and cis interactions between ligands and receptors on the same cell membrane. Additionally, because Notch activity is highly dependent on contextual cues, JAG1
Mem and Notch1 Mem expression may facilitate communication between tumor cells and the tumor microenvironment. Cytoplasmic JAG1 or Notch1 may be degraded or subject to post-translational modifications. In addition, recent evidence supports the hypothesis that the Notch-DSL pathway is bidirectional (24) , suggesting that the membrane localization of JAG1-Notch1 has a unique role in Notch signaling.
In this study, the close correlation between membranelocalized JAG1-Notch1 and extra-hepatic metastasis supplied further evidence for Notch signaling in promoting HCC progression. Consistent with our findings, Notch signaling was previously shown to be involved in metastasis through an EMT mechanism in tumors and was correlated with the upregulation of E-cadherin expression in HCC (2, 25) . Furthermore, the inhibition of Notch signaling using a DAPT inhibitor was able to decrease the invasive potential of HCC (26) .
To confirm the role of the JAG1-Notch1 cascade in HCC metastasis, we further evaluated the expression of the target gene OPN and the relationship between OPN and JAG1. As Mem -Notch1 Mem tumors further suggests the crucial role of the active JAG1-Notch1-OPN cascade in extra-hepatic metastasis. Furthermore, OPN was previously identified as a pivotal metastasis-related gene in the genomic profiling of multiple HCC pairs, suggesting that OPN is tumor specific (27) . Additionally, the critical role of OPN in metastatic HCC has been well demonstrated (28) . Therefore, the JAG1-Notch1-OPN cascade in HCC metastasis has tumor-specific features.
In conclusion, the spatial distribution of Notch signaling components represents another crucial factor regulating the Notch cascade in HCC. The tumor-specific JAG1-Notch1-OPN cascade was determined to be predictive of extra-hepatic HCC metastasis and poor prognosis, which suggests that this pathway may represent a therapeutic target for HCC.
